Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0ZM8B
|
|||
Former ID |
DIB008724
|
|||
Drug Name |
FK-409
|
|||
Synonyms |
nor-3; 3-Hexenamide, 4-ethyl-2-(hydroxyimino)-5-nitro-; 92454-83-6; 163180-49-2; ACMC-20eif3; AC1OAT8P; 4-ethyl-2-hydroxyimino-5-nitrohex-3-enamide; CTK3H0114; CTK4D1460
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Angina pectoris [ICD-11: BA40; ICD-9: 413] | Phase 2 | [1] | |
Company |
Fujisawa Pharmaceutical Co Ltd
|
|||
Structure |
Download2D MOL |
|||
Formula |
C8H13N3O4
|
|||
Canonical SMILES |
CCC(=CC(=NO)C(=O)N)C(C)[N+](=O)[O-]
|
|||
InChI |
1S/C8H13N3O4/c1-3-6(5(2)11(14)15)4-7(10-13)8(9)12/h4-5,13H,3H2,1-2H3,(H2,9,12)/b6-4+,10-7-
|
|||
InChIKey |
MZAGXDHQGXUDDX-JSRXJHBZSA-N
|
|||
CAS Number |
CAS 92454-60-9
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Soluble guanylyl cyclase (GUCY2D) | Target Info | Modulator | [2], [3] |
References | Top | |||
---|---|---|---|---|
REF 1 | The interaction of FK409, a novel nitric oxide releaser, and peripherally administered morphine during experimental inflammation. Anesth Analg. 1998 Feb;86(2):367-73. | |||
REF 2 | Vasorelaxant mechanism of the new vasodilator, FK409. Eur J Pharmacol. 1993 Aug 15;246(3):205-12. | |||
REF 3 | Tolerance to the vascular effect of a novel nitric oxide-donating vasodilator, FK409. Eur J Pharmacol. 1994 Aug 1;260(2-3):163-8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.